相似文献
1
Quantitative analysis of a urine-based assay for detection of lipoarabinomannan in patients with tuberculosis.
J Clin Microbiol. 2010 Aug;48(8):2972-4. doi: 10.1128/JCM.00363-10. Epub 2010 Jun 9.
2
Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting.
J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):145-51. doi: 10.1097/QAI.0b013e3181b98430.
3
Utility of urine lipoarabinomannan (LAM) in diagnosing tuberculosis and predicting mortality with and without HIV: prospective TB cohort from the Thailand Big City TB Research Network.
Int J Infect Dis. 2017 Jun;59:96-102. doi: 10.1016/j.ijid.2017.04.017. Epub 2017 Apr 27.
4
Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review.
BMC Infect Dis. 2012 Apr 26;12:103. doi: 10.1186/1471-2334-12-103.
5
Detection of Mycobacterium tuberculosis lipoarabinomannan and CFP-10 (Rv3874) from urinary extracellular vesicles of tuberculosis patients by immuno-PCR.
Pathog Dis. 2019 Jul 1;77(5). doi: 10.1093/femspd/ftz049.
6
Detection of lipoarabinomannan in urine and serum of HIV-positive and HIV-negative TB suspects using an improved capture-enzyme linked immuno absorbent assay and gas chromatography/mass spectrometry.
Tuberculosis (Edinb). 2018 Jul;111:178-187. doi: 10.1016/j.tube.2018.06.004. Epub 2018 Jun 6.
7
The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study.
BMC Med. 2017 Aug 4;15(1):145. doi: 10.1186/s12916-017-0888-3.
8
Early morning urine collection to improve urinary lateral flow LAM assay sensitivity in hospitalised patients with HIV-TB co-infection.
BMC Infect Dis. 2017 May 12;17(1):339. doi: 10.1186/s12879-017-2313-0.
9
Detection of lipoarabinomannan (LAM) in urine is indicative of disseminated TB with renal involvement in patients living with HIV and advanced immunodeficiency: evidence and implications.
Trans R Soc Trop Med Hyg. 2016 Mar;110(3):180-5. doi: 10.1093/trstmh/trw008.
10
Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational study.
PLoS Med. 2019 Apr 30;16(4):e1002792. doi: 10.1371/journal.pmed.1002792. eCollection 2019 Apr.
引用本文的文献
1
Parallel use of low-complexity automated nucleic acid amplification tests and lateral flow urine lipoarabinomannan assays to detect tuberculosis disease in adults and adolescents living with HIV.
Cochrane Database Syst Rev. 2025 Jun 10;6(6):CD016070. doi: 10.1002/14651858.CD016070.pub2.
2
Blood and urine early treatment response biomarkers in HIV-associated disseminated tuberculosis.
South Afr J HIV Med. 2025 Apr 9;26(1):1664. doi: 10.4102/sajhivmed.v26i1.1664. eCollection 2025.
3
Parallel use of low-complexity automated nucleic acid amplification tests and lateral flow urine lipoarabinomannan assays to detect tuberculosis disease in adults and adolescents living with HIV.
Cochrane Database Syst Rev. 2024 May 13;5(5):CD016070. doi: 10.1002/14651858.CD016070.
4
Diagnostic accuracy of a sequence-specific -DNA hybridization assay in urine: a case-control study including subclinical TB cases.
Microbiol Spectr. 2024 Jun 4;12(6):e0042624. doi: 10.1128/spectrum.00426-24. Epub 2024 May 8.
5
Diagnostic value of chemiluminescence for urinary lipoarabinomannan antigen assay in active tuberculosis: insights from a retrospective study.
Front Cell Infect Microbiol. 2023 Dec 8;13:1291974. doi: 10.3389/fcimb.2023.1291974. eCollection 2023.
6
A Breakthrough in the Challenges of Tuberculosis Diagnosis: Lateral Flow Urine Lipoarabinomannan (LAM) Assay for the Diagnosis of Active Tuberculosis in a Subset of Human Immuno Deficiency Virus (HIV) Patients at Hawassa University Comprehensive Specialized Hospital, Hawassa, Ethiopia.
Int Med Case Rep J. 2022 Aug 2;15:393-397. doi: 10.2147/IMCRJ.S373197. eCollection 2022.
7
Diagnostic Advances in Childhood Tuberculosis-Improving Specimen Collection and Yield of Microbiological Diagnosis for Intrathoracic Tuberculosis.
Pathogens. 2022 Mar 23;11(4):389. doi: 10.3390/pathogens11040389.
8
Diagnostic Accuracy of Urine Lipoarabinomannan Testing in Early Morning Urine versus Spot Urine for Diagnosis of Tuberculosis among People with HIV.
Microbiol Spectr. 2022 Apr 27;10(2):e0020822. doi: 10.1128/spectrum.00208-22. Epub 2022 Mar 31.
9
Multidimensional analysis of the host response reveals prognostic and pathogen-driven immune subtypes among adults with sepsis in Uganda.
Crit Care. 2022 Feb 8;26(1):36. doi: 10.1186/s13054-022-03907-3.
10
Diagnostic value of Lipoarabinomannan antigen for detecting Mycobacterium tuberculosis in adults and children with or without HIV infection.
J Clin Lab Anal. 2022 Feb;36(2):e24238. doi: 10.1002/jcla.24238. Epub 2022 Jan 16.
本文引用的文献
1
HIV-associated tuberculosis: clinical update.
Clin Infect Dis. 2010 May 15;50(10):1377-86. doi: 10.1086/652147.
2
Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developments.
Curr Opin Pulm Med. 2010 May;16(3):262-70. doi: 10.1097/MCP.0b013e328337f23a.
3
Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples.
PLoS One. 2010 Mar 24;5(3):e9848. doi: 10.1371/journal.pone.0009848.
4
Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease.
AIDS. 2009 Sep 10;23(14):1875-80. doi: 10.1097/qad.0b013e32832e05c8.
5
Diagnostic accuracy of commercial urinary lipoarabinomannan detection in African tuberculosis suspects and patients.
Int J Tuberc Lung Dis. 2009 Oct;13(10):1253-9.
6
Blinded evaluation of commercial urinary lipoarabinomannan for active tuberculosis: a pilot study.
Int J Tuberc Lung Dis. 2009 Aug;13(8):989-95.
7
Low sensitivity of a urine LAM-ELISA in the diagnosis of pulmonary tuberculosis.
BMC Infect Dis. 2009 Aug 28;9:141. doi: 10.1186/1471-2334-9-141.
8
Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting.
J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):145-51. doi: 10.1097/QAI.0b013e3181b98430.
9
Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings.
Lancet Infect Dis. 2009 Mar;9(3):173-84. doi: 10.1016/S1473-3099(09)70043-X.
10
HIV-associated tuberculosis: diagnostic and treatment challenges.
Semin Respir Crit Care Med. 2008 Oct;29(5):525-31. doi: 10.1055/s-0028-1085703. Epub 2008 Sep 22.
Zotero 插件